NSB
" Neuroscientific Biopharmaceuticals (NSB) is partnering with The Institute of Respiratory Health and The University of Western Australia to test the effectiveness of EmtinB and other Metallothionein derived peptides (EmtinAc, EmtinAn, EmtinBn) as potential therapy for long term respiratory complications of Covid-19."
about to come out of a trading halt - could pop.
